Your SlideShare is downloading. ×
0
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"

708

Published on

Workshop 3 - Registries …

Workshop 3 - Registries
"Outcome of the RD Task Force and EPPOSI Workshop"
on registries, Tsveta Schyns, ENRAH
Eurordis Membership Meeting 2011 Amsterdam
13 – 14 May 2011
Tsveta Schyns

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
708
On Slideshare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
4
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Summary of outcomes from 2009 EPPOSI Registries Workshop and the 2009 RDTF Report Tsveta Schyns Founder and Secretary General of ENRAH Eurordis Membership Meeting 2011 Amsterdam 13 – 14 May 2011
  • 2. RARE Diseases Characteristics• Restricted information from randomized clinical trials (RCT)• Often conditional regulatory and reimbursement approvals• Need for real world data• Low disease awareness, which affects referral and diagnosis• Need for communication• Not optimal disease management• Need for improved treatment guidelines Eurordis Membership Meeting 2011 Amsterdam 13 – 14 May 2011
  • 3. Rare Diseases Task Force Workshop 13 March 2008, Paris, 2009 Report. I• the scarcity of RD cases imposes a large geographical coverage of the data collection→ multiple collaborations and exchanges of data, usually transnational• 371 Registries in 20 EU Countries in Orphanet database→ 13 of which described as European or Global Eurordis Membership Meeting 2011 Amsterdam 13 – 14 May 2011
  • 4. Rare Diseases Task Force Workshop 13 March 2008, Paris, Report. II→ Regulations concerning registries are in early stages in most European countries→ With the multiplicity of actors and of rules at MS level, the situation is difficult to comprehend→ No guidelines are available yet on best practices for exchanging and sharing data→ The notion of return of benefits to research subjects or communities is fairly recent. Eurordis Membership Meeting 2011 Amsterdam 13 – 14 May 2011
  • 5. Purposes of PR in the field of RD RDTF Workshop 2008. III→ Establish natural history→ Provide an inventory of patients for future research→ Assess and compare therapies’ effectiveness→ Measure quality of care and services A tool to assess real life situation and facilitate research on RD Eurordis Membership Meeting 2011 Amsterdam 13 – 14 May 2011
  • 6. 1 st EPPOSI Workshopon Patient Registries for Rare Disorders 18-19 March 2009 Brussels BelgiumNeed for Data Collection to→ Increase Knowledge on Rare Disorders and→ Optimize Disease Management and Care Eurordis Membership Meeting 2011 Amsterdam 13 – 14 May 2011
  • 7. Programme First EPPOSI Workshop→ Current Situation of registries in Europe→ Challenges for registries from the point of view of stakeholders→ Issues at stake with registries in Europe→ Registration of Patient Data: legal and ethical issues→ Data collection, management and analysis→ Governance of registries → Concrete recommendations Eurordis Membership Meeting 2011 Amsterdam 13 – 14 May 2011
  • 8. Planning and Operating Patient Registries1. Setting the scope → strategy2. Protocol and CRF design3. Implement and Roll Out4. Daily Operations5. Output Eurordis Membership Meeting 2011 Amsterdam 13 – 14 May 2011
  • 9. 1. Setting the scope Why and what to document?• Each and every registry is different : there is no one recipe for all → Coverage: Local, Regional, National, Global → Initiator: Scientist (s), National Health/HTA, Patient Organizations or Pharmaceutical Company• Recommendations: To establish a Working Group/Forum with experience in setting up registries for → Best Practice Templates → Downloadable Software Eurordis Membership Meeting 2011 Amsterdam 13 – 14 May 2011 9
  • 10. 1. Setting the scope Related Issues to be brought up→The link between the data entry and data output for optimal design→ The value of Disease history data for optimal evaluation of treatment effectiveness→ Systems at a EU level to ensure collaboration between different registries→ Central registration of all patient registries involving patients from Europe Eurordis Membership Meeting 2011 Amsterdam 13 – 14 May 2011 10
  • 11. 2. Protocol and CRF design• Protocol design→ What data to collect ?→ Who will report: Clinician or Patient?• Demands on application used for data entry:→ User friendliness→ Report generation on all or a selected patient cohort→ Operation manuals• Center Criteria→ Number of centers→ Specialist/hospitals/GPRecommendations: Establish a Working Group/Forum Eurordis Membership Meeting 2011 Amsterdam 13 – 14 May 2011 11
  • 12. 2. Protocol and CRF design Related Issues to be brought up→ The value of systems for data entry: • user friendliness • fexibility to difference in standard of care between countries and to changes in management approaches over time • data structure to assure flexibility in data analysis • in build data validation to assure data quality not just free/cheap systems→ The fundamental difference between Clinical Trials and Patient Registries- a RD Patient Registry needs to be continuously adapted to varying definitions (e. g. diagnostic criteria) and varying scopes→ The relationship between a RD Patient Registry and Guidelines for diagnosis, treatment and care→ RD Patient Registries should be based on a Network of centers of expertise in the RD Eurordis Membership Meeting 2011 Amsterdam 13 – 14 May 2011 12
  • 13. 3. Implement and Roll Out• Protocol and Informed consent (translations)• Submission to authorities and EC (if applicable)• Training of centers Recommendations: → Training of ethics committees → Reference centers with experience in data management Eurordis Membership Meeting 2011 Amsterdam 13 – 14 May 2011 13
  • 14. 3. Implement and Roll Out Related Issues to be brought up→ Patients with RD are often followed by several specialists→ Networks of Centers of expertise do not always exist→ Data providing centers differ and require different approach and support→ Being part of registries on rare disease - mandatory for receiving a new treatment?→ Are Patients in control of ”their” data?How long should a RD Patient registry run? Is the IC a life-long commitment? Eurordis Membership Meeting 2011 Amsterdam 13 – 14 May 2011 14
  • 15. 4. Daily Operations• Data management; Data Cleaning off/onsite• AE monitoring follow up/coding• Communication/motivationRecommendations: → Dedicated documenters to visit clinics and enter data (e.g. within the national plans) → Credits for Professionals and Reference centers Eurordis Membership Meeting 2011 Amsterdam 13 – 14 May 2011 15
  • 16. 4. Daily Operations Related Issues to be brought up→ Assure complete accurate data for regulatory purposes, no monetary or other incentives→ The value of motivation ” what is in it for me? “→ Data from patient registries to be used for P&R→ Networks of centers of expertise on the RD Eurordis Membership Meeting 2011 Amsterdam 13 – 14 May 2011 16
  • 17. 5. Output from Patient Registries• Scientific publications in peer reviewed journals• Reports to Authorities (regulatory and P&R)• Presentation at congresses within the fieldRecommendations (data are underused): → Integrate data from different sources → Data mining and review (but who and how was not discussed) Eurordis Membership Meeting 2011 Amsterdam 13 – 14 May 2011 17
  • 18. 4. Output from Patient Registries Related Issues to be brought up.I→ The value of feed back on output to all stakeholders→ The use of other statistical approaches -for missing or biased data→ Data mining to utilize all collected data hidden in patient registries→ Output is needed to increase disease awareness→Improve diseases management by reviewing, updating and publishing Guidelines on RD Eurordis Membership Meeting 2011 Amsterdam 13 – 14 May 2011 18
  • 19. 4. Output from Patient Registries Related Issues to be brought up.IIHollak et al 2011. Orphanet Journal of Rare Diseases:→ Fragmentation : Disease Registries versus Product Registries; Compare patient‘s outcomes;One disease Register rather than multiple registries→ enhance the Quality and Completeness of the data-systems should be developed that support physicians to submit data, in line with defined requirements→ registries should be supervised and analyses performed by an Independent body and access to data should be possible on request.→ registries should be audited at regular intervals. Eurordis Membership Meeting 2011 Amsterdam 13 – 14 May 2011 19
  • 20. Conclusions• 8 years with the European registry for AHC Patients & the nEUroped registry:→ support by and support to RD Networks of Centers of expertise→ relate to the existing /draft and update/Guidelines for RD diagnosis, treatment and care→ register in a centralized (European) and continuously updated system Eurordis Membership Meeting 2011 Amsterdam 13 – 14 May 2011
  • 21. THANK YOU !Special thanks to: → ENRAH and nEUroped Consortium → Elizabeth Hernberg-Ståhl Founder Late Phase Solutions Europe & Co-Chair of EPPOSI Workshop 2009 Thank you all! Eurordis Membership Meeting 2011 Amsterdam 13 – 14 May 2011

×